NorthView Acquisition (NVACR) Short Interest Ratio & Short Volume

Short interest is the volume of NorthView Acquisition shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 400 shares of NVACR short. Learn More on NorthView Acquisition's current short interest.

Here is how the short interest of companies in the industry of "medical equipment" compare to NorthView Acquisition: GE HealthCare Technologies Inc. (1.49%), Koninklijke Philips (0.40%), Zimmer Biomet Holdings, Inc. (3.01%), Smith & Nephew plc (0.43%), Solventum Co. (3.33%), Penumbra, Inc. (4.13%), Stevanato Group S.p.A. (5.46%), Glaukos Co. (6.49%), Inari Medical, Inc. (4.24%), iRhythm Technologies, Inc. (8.65%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling NVACR is an investing strategy that aims to generate trading profit from NorthView Acquisition as its price is falling. NVACR shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NorthView Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NVACR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVACR, twice per month. The most recent reporting period available is May, 15 2025.